News and Press Releases
ALK receives positive CHMP opinion for EURneffy 1mg (nasal adrenaline spray) for emergency anaphylaxis treatment in children (≥15kg)
30 January 2026 -- Hørsholm – Denmark -- Today ALK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2026
Samsung Bioepis Reaches Settlement Agreement for Eylea (Aflibercept) Biosimilar in Europe and the Rest of the World
30 January 2026 -- Incheon, Korea -- Samsung Bioepis Co., Ltd. has signed a settlement and license agreement with Regeneron and Bayer concerning the commercialization of SB15, a biosimilar to...
Category: Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2026
Pharmapack announces expansion to Asia with new event in Singapore, set for November 2026
Paris, France – January 21st, 2026 – Pharmapack, the leading European platform for pharmaceutical packaging and drug delivery innovation, today announced the launch of Pharmapack Asia, coming to Singapore in...
Category:
Posted: January 30, 2026
Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Ravensburg, January 29, 2026 – Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirmed its plans to build a state-of-the-art production facility...
Category:
Posted: January 30, 2026
MetP Pharma’s Neural Targeting Drug Delivery Technology Sets a New Benchmark for Brain Delivery of Peptides
Intranasal nose-to-brain delivery achieves superior brain exposure with low systemic burden, outperforming transporter-based BBB technologies in preclinical studies 29 January 2026 -- Emmetten, Switzerland -- MetP Pharma AG, a pioneer...
Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: January 29, 2026
Schynweg 7 Office: St. Anna-Weg 16 P.O.Box 138 6376 Emmetten / Switzerland
Datwyler Launches Industry’s First 20mL Universal Plunger for Large-Volume On-Body Delivery
MIDDLETOWN, DE: 21 January 2026 –Datwyler, a leading provider of high-quality, system-critical elastomer components, expanded its NeoFlex™ range of fully coated plungers with a solution for large-volume cartridges containing 20mL....
Category:
Posted: January 28, 2026
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
27 January 2026 -- Illinois, US -- Tempus AI, Inc, a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 27, 2026
Bial Achieves Key Milestone in Phase 2b ACTIVATE Study ofBIA 28-6156 in GBA1-Associated Parkinson’s Disease
75% of patients have completed the Week 78 Last Study Visit Topline results expected in mid-2026 27 January 2026 -- Porto, Portugal -- Bial, an innovation-driven biopharmaceutical company focused on...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 27, 2026
Recipharm expands manufacturing to meet demanding FDA requirements
Established a new, dedicated non-bacterial beta-lactam manufacturing facility in response to FDA guidance Secured a strategic partnership with an innovative biopharma company seeking rapid regulatory compliance Developed a scalable platform...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 26, 2026
Journal of Prevention of Alzheimer’s Disease publishes trial results showing HMTM potentially offers accessible oral treatment option for patients with early Alzheimer’s disease
26 January 2026 -- Scotland, UK -- TauRx Therapeutics Management Ltd today announced results from its Phase III LUCIDITY trial evaluating the efficacy and safety of hydromethylthionine mesylate (HMTM) in...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 26, 2026
Vetter Achieves Top Sustainability Rating and Expands Climate Goal Commitments
Ravensburg, January 21, 2026: Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has strengthened its sustainability strategy with distinguished recognitions: the internationally renowned EcoVadis Platinum rating as well...
Category:
Posted: January 26, 2026
Datwyler Launches Industry’s First 20mL Universal Plunger for Large-Volume On-Body Delivery
MIDDLETOWN, DE: 21 January 2026 –Datwyler, a leading provider of high-quality, system-critical elastomer components, expanded its NeoFlex™ range of fully coated plungers with a solution for large-volume cartridges containing 20mL. Announced at...
Category:
Posted: January 26, 2026
MetP Pharma’s Enabling Technology Creates a New Brain-Targeted GLP-1 Opportunity
Preclinical data in rats demonstrate dose-dependent and rapid brain targeting of intranasal semaglutide with low systemic exposure 22 January 2026 -- Emmetten, Switzerland -- MetP Pharma AG, a pioneer in nose-to-brain...
Category: Biotechnology, Clinical Trials, Drug Delivery, Other, Pharmaceutical
Posted: January 22, 2026
Schynweg 7 Office: St. Anna-Weg 16 P.O.Box 138 6376 Emmetten / Switzerland
Dawnzera (donidalorsen) granted European Union marketing authorisation for the prevention of hereditary angioedema
Donidalorsen is a first-in-class RNA-targeted prophylactic therapy for patients with hereditary angioedema (HAE) Donidalorsen demonstrated a significant reduction in HAE attack rate compared with placebo in the Phase 3 OASIS-HAE...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 21, 2026
Gallions Wexham Springs Framewood Road Wexham SL3 6PJ
Levicept Announces FDA Acceptance of IND Application for LEVI-04, a Potentially Disease-Modifying Treatment for Osteoarthritis
20 January 2026 -- Sandwich, UK -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announces the US Food and...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 20, 2026
